These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27825364)

  • 21. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
    Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
    Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
    Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-Regional Proadrenomedullin and Mid-Regional Proatrial Natriuretic Peptide Clearance Predicts Poor Outcomes Better Than Single Baseline Measurements in Critically Ill Patients With Pneumonia: A Retrospective Cohort Study.
    Van Oers J; Krabbe J; Kemna E; Kluiters Y; Vos P; De Lange D; Girbes A; Beishuizen A
    Cureus; 2021 May; 13(5):e15285. PubMed ID: 34221750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
    Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
    BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
    Eggers KM; Venge P; Lindahl B; Lind L
    Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death.
    Valenzuela-Sánchez F; Valenzuela-Méndez B; Bohollo de Austria R; Rodríguez-Gutiérrez JF; Estella-García Á; Fernández-Ruiz L; González-García MÁ; Rello J
    Minerva Anestesiol; 2019 Apr; 85(4):366-375. PubMed ID: 30207133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Liu D; Xie L; Zhao H; Liu X; Cao J
    BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
    Gille J; Ostermann H; Dragu A; Sablotzki A
    J Burn Care Res; 2017; 38(5):290-298. PubMed ID: 28221298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
    Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Then C; Rottenkolber M; Lechner A; Meisinger C; Heier M; Koenig W; Peters A; Rathmann W; Bidlingmaier M; Reincke M; Seissler J
    Atherosclerosis; 2016 Sep; 252():88-96. PubMed ID: 27508320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
    Kaiser R; Abdul-Khaliq H; Wilkens H; Herrmann E; Raedle-Hurst TM
    Eur J Heart Fail; 2014 Oct; 16(10):1082-8. PubMed ID: 25201135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
    Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluid management in the intensive care unit: bioelectrical impedance vector analysis as a tool to assess hydration status and optimal fluid balance in critically ill patients.
    Basso F; Berdin G; Virzì GM; Mason G; Piccinni P; Day S; Cruz DN; Wjewodzka M; Giuliani A; Brendolan A; Ronco C
    Blood Purif; 2013; 36(3-4):192-9. PubMed ID: 24496190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.